Renal Sympathetic Nerve Activity After Dexmedetomidine in Nerve-Intact and Baroreceptor-Denervated Rabbits
- 1 September 1996
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 83 (3) , 477-481
- https://doi.org/10.1213/00000539-199609000-00006
Abstract
To determine the effects of intravenous dexmedetomidine (DMED) on the sympathetic nervous system and to elucidate the mechanism of hypotension, we administered 3 micro gram/kg of DMED to nerve-intact and baroreceptor-denervated rabbits and compared the changes in renal sympathetic nerve activity (RSNA) and hemodynamic variables. In nerve-intact animals, mean arterial pressure (MAP) was increased briefly and then decreased significantly. Changes in RSNA were reciprocal to those of MAP. Heart rate decreased throughout the period of observation. In baroreceptor-denervated rabbits, both MAP and RSNA decreased significantly (-39.4% +/- 3.8% and -21.3% +/- 4.7%, respectively) after the initial increase of MAP. Twenty minutes after administration, hypotension had still continued (-21.1% +/- 3.2%) although RSNA returned to the baseline value. These results indicate that suppression of sympathetic nerve discharge is indeed one of the mechanisms of DMED-induced hypotension, although it may not be the principal one. (Anesth Analg 1996;83:477-81)Keywords
This publication has 18 references indexed in Scilit:
- Effects of Intravenous Dexmedetomidine in HumansAnesthesiology, 1992
- Oral Dexmedetomidine Attenuates Hemodynamic Responses during Emergence from General Anesthesia in Chronically Instrumented DogsAnesthesiology, 1991
- Attenuation of Arterial Baroreceptor Reflex Response to Acute Hypovolemia During Induced HypotensionAnesthesiology, 1990
- Dexmedetomidine, an α2-Adrenoceptor Agonist, Reduces Anesthetic Requirements for Patients Undergoing Minor Gynecologic SurgeryAnesthesiology, 1990
- Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonistEuropean Journal of Pharmacology, 1988
- Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2‐adrenoceptor agonist, in healthy volunteers.British Journal of Clinical Pharmacology, 1987
- Antinociceptive activity of clonidine and its potentiation of morphine analgesiaEuropean Journal of Pharmacology, 1979
- Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidineBrain Research, 1975
- Intravenous clonidine in hypertensive patientsClinical Pharmacology & Therapeutics, 1973
- Evidence for a central noradrenaline receptor stimulation by clonidineLife Sciences, 1970